Distribution of LDL-C Reduction with Atorvastatin, Rosuvastatin and Simvastatin: A VOYAGER Meta-Analysis

被引：0
|
作者：
Karlson, Bjorn W. [1 ,2 ]
Palmer, Michael K. [3 ]
Nicholls, Stephen J. [4 ]
Lundman, Pia [5 ]
Barter, Philip J. [6 ]
机构：
[1] AstraZeneca, Molndal, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden
[3] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester M15 6BH, Lancs, England
[4] Univ Adelaide, South Australian Hlth & Med Res Inst, Adelaide, SA, Australia
[5] Karolinska Inst, Danderyd Hosp, Stockholm, Sweden
[6] Univ New S Wales, Sydney, NSW, Australia
来源：
CARDIOLOGY | 2015年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-06
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [41] Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice
    Gandhi, Sanjay K.
    Jarbrink, Krister
    Fox, Kathleen M.
    Brandrup-Wognsen, Gunnar
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) : 2817 - 2828
  • [42] EFFICACY AND SAFETY OF BEMPEDOIC ACID FOR LDL-C REDUCTION IN STATIN-INTOLERANT PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Afzal, Muhammad Adil
    Abdullah, Muhammad
    Khalid, Noman
    Hassan, Mubariz Ahmed
    Shamoon, Yezin F.
    Noori, Muhammad Atif M.
    Muddassir, Salman M.
    Vasudev, Rahul
    Shamoon, Fayez E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (12) : 673 - 673
  • [43] Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol A meta-analysis of trials with East Asian populations
    Zhang, L.
    Zhang, S.
    Yu, Y.
    Jiang, H.
    Ge, J.
    HERZ, 2020, 45 (06) : 594 - 602
  • [44] Comparison of efficiency between Rosuvastatin and Atorvastatin in reducing low-density lipoprotein (LDL-C) in patients with diabetes mellitus
    Khokhar, Saad Ahmed
    Rehman, Rai Muhammad Farooq Ur
    Masood, Seemal
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2022, 72 (11) : 2288 - 2290
  • [45] The cost-effectiveness of atorvastatin, rosuvastatin and simvastatin in treating patients to LDL-cholesterol targets
    Niskanen, L.
    Peura, P. K.
    Hallinen, T.
    Soini, E.
    Martikainen, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 860 - 860
  • [46] IMPORTANCE OF BASELINE LDL-C IN THE ASSOCIATION BETWEEN LDL-C LOWERING AND CARDIOVASCULAR RISK: A META-REGRESSION ANALYSIS
    Hawe, E.
    Meleth, S.
    Wolowacz, S.
    Bilitou, A.
    ATHEROSCLEROSIS, 2022, 355 : E266 - E267
  • [47] CONSISTENCY OF LDL-C REDUCTION WITH EVOLOCUMAB: AN ANALYSIS FROM FOURIER
    Qamar, Arman
    Giugliano, Robert P.
    Keech, Anthony C.
    Kuder, Julia F.
    Murphy, Sabina A.
    Liu, Thomas
    Kurtz, Christopher
    Wasserman, Scott M.
    Sever, Peter S.
    Pedersen, Terje R.
    Sabatine, Marc S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1727 - 1727
  • [48] Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions A Systematic Review and Meta-analysis
    Silverman, Michael G.
    Ference, Brian A.
    Im, Kyungah
    Wiviott, Stephen D.
    Giugliano, Robert P.
    Grundy, Scott M.
    Braunwald, Eugene
    Sabatine, Marc S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (12): : 1289 - 1297
  • [49] Meta-Analysis Comparing Rosuvastatin and Atorvastatin in Reducing Concentration of C-Reactive Protein in Patients With Hyperlipidemia
    Ma, Qian
    Zhou, Yujie
    Zhai, Guangyao
    Gao, Fei
    Zhang, Linlin
    Wang, Jianlong
    Yang, Qing
    Cheng, Wanjun
    ANGIOLOGY, 2016, 67 (06) : 526 - 535
  • [50] Effectiveness of rosuvastatin compared with atorvastatin on NCEP ATP-III LDL-C goal attainment outside of controlled study settings
    Kamat, SA
    Bullano, MF
    Gandhi, S
    Wertz, DA
    Cziraky, MJ
    Willey, VJ
    CIRCULATION, 2005, 111 (20) : E343 - E343
12345